Additionally, mutations in PIK3CA (encoding the catalytic subunit of PI3K) and loss of PTEN (a tumor suppressor that negatively regulates PI3K signaling) lead to hyperactivation of the PI3K/AKT/mTOR pathway. The gene discussed is AKT1; the disease is neoplasm.